Skip to content Skip to navigation

News and Press Releases

During a recent episode of "The Future of Everything," host Russ Altman and guest Ami Bhatt discuss the factors that contribute to microbiome health.
Aug 13 2019 | Stanford News
The Stanford Microbiome Therapies Initiative is backed by gifts from Marc and Lynne Benioff and Mark and Debra Leslie and is focused on developing and testing new disease therapies
Aug 8 2019 | Stanford ChEM-H
Stanford ChEM-H Institute Scholar Michael Fischbach explains why the microbiome is worth studying, the ways his lab hopes to advance our understanding of these complex communities, and how the people and mission of ChEM-H drew him to Stanford.
The bacteria in our gut make tiny, previously unidentified proteins that could shed light on human health and advance drug development.
Aug 8 2019 | Stanford Medicine
The bacteria in our gut make thousands of tiny, previously unidentified proteins that could shed light on human health and advance drug development, Stanford researchers have found.
Aug 7 2019 | Stanford Medicine
Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.
Aug 7 2019 | Stanford Medicine
Applying a gel to internal tissues of animals after cardiac surgery significantly limits the formation of adhesions, a problematic form of scar tissue, Stanford researchers have found.
Stanford researchers discover a gel that, when applied to animal hearts, vastly reduces the formation of adhesions, scar tissue that cause complications.
Stanford researchers watch in real time bacteria building their protective outer shell. Their findings may help develop treatments for bacterial pathogens.
Jul 17 2019 | Stanford ChEM-H
Postdoc Monica Olcina and Ryan Kim BS ’17 speak about their work in enhancing patient responses to radiation, how their collaboration has evolved, and the importance of medical research.
Jul 17 2019 | Stanford Medicine
Stanford researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.
Jul 16 2019 | Stanford ChEM-H
Marie Hollenhorst talks about the allure of studying the blood, a life split between the clinic and the lab, and how the Stanford ChEM-H Physician-Scientist Fellowship has shaped her career.
Jul 10 2019 | Stanford News
Observations of cellular life in a local marsh led researchers to the discovery of a new type of intercellular communication.
The discovery of an eco-friendly form of genetic engineering for plants has the potential to open up more farmland for food production.
More effective drugs and treatments could eventually result from understanding how physical changes in the area around a tumor can make the disease worse.
Jun 28 2019 | Stanford ChEM-H
For years, researchers studied key enzymes in largely piecemeal fashion. Now, Stanford researchers are using new techniques to explore previously inaccessible aspects of the molecules that make life happen.
Diagnosis of inflammatory bowel disease currently requires an invasive procedure. New research identifies a way to identify the disease using a blood draw.
Jun 21 2019 | SLAC News Center
A close-up look at how microbes build their crystalline shells has implications for understanding how cell structures form, preventing disease and developing nanotechnology.
The parasite that causes malaria is remarkably adept at developing resistance to the drugs devised to combat it. But new research suggests a solution.
Jun 10 2019 | Stanford News
Stanford chemists have identified and synthesized two new healing compounds in scorpion venom that are effective at killing staph and tuberculosis bacteria.

Pages

Subscribe to